(Total Views: 652)
Posted On: 12/01/2022 10:56:51 AM
Post# of 149068
Scott Kelly is presenting here today:
https://patch.com/massachusetts/boston/calend...ummit-2022
2:00 pm Driving Innovation in Patient Selection: Rethinking Inclusion & Exclusion Criteria
Scott Kelly
Chief Medical Officer, CytoDyn
Synopsis
Investigating clinical trials for NASH in HIV-infected patients
Evaluating novel biomarker outcomes in NASH and considering comorbidities
Beyond NASH: driving studies in cardiovascular and metabolic disorders
https://patch.com/massachusetts/boston/calend...ummit-2022
2:00 pm Driving Innovation in Patient Selection: Rethinking Inclusion & Exclusion Criteria
Scott Kelly
Chief Medical Officer, CytoDyn
Synopsis
Investigating clinical trials for NASH in HIV-infected patients
Evaluating novel biomarker outcomes in NASH and considering comorbidities
Beyond NASH: driving studies in cardiovascular and metabolic disorders
(4)
(0)Scroll down for more posts ▼
